Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report

BACKGROUND: Immune checkpoint inhibitors (ICIs) have provided more options in the treatment of lung cancer. However, ICIs can cause several unfavorable reactions generally referred to as immune-related adverse effects. CASE PRESENTATION: In this report, we present the case of a 52-year-old woman wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Honjo, Osamu, Kubo, Terufumi, Sugaya, Fumiko, Nishizaka, Takahiro, Kato, Koji, Hirohashi, Yoshihiko, Takahashi, Hiroki, Torigoe, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448268/
https://www.ncbi.nlm.nih.gov/pubmed/30944043
http://dx.doi.org/10.1186/s40425-019-0582-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448268/
https://www.ncbi.nlm.nih.gov/pubmed/30944043
http://dx.doi.org/10.1186/s40425-019-0582-4

Ejemplares similares